AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31128336
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with antibodies to infliximab
Trial: 29886103
Drug: Rivaroxaban 10
RxNorm normalized name: rivaroxaban 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rivaroxaban 10 mg/12h
Trial: 20932651
Drug: Intensity-modulated radiotherapy
RxNorm normalized name: California intense cedar pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensity-modulated radiotherapy (IMRT) with concurrent temozolomide (TMZ) chemotherapy, 60 Gy total dose, escalating from 3 Gy/fraction to 6 Gy/fraction, concurrent TMZ at 75 mg/m²/d for 28 days, adjuvant TMZ at 150-200 mg/m²/d for 5 days every 28 days.
Trial: 16196417
Drug: Fish oil
RxNorm normalized name: Fish oil
DrugBank: Fish oil (DB13961)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fish oil supplementation (4.5 g/d for the first 4 months of lactation)
Trial: 9542208
Drug: Colony-stimulating factors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colony-stimulating factors (G-CSF and GM-CSF) as adjunctive care
Trial: 7651658
Drug: nalbuphine 10
RxNorm normalized name: nalbuphine 10 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nalbuphine 10 mg intravenously
Trial: 7651658
Drug: meperidine 50
RxNorm normalized name: meperidine 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: meperidine 50 mg intravenously
Trial: 326593
Drug: Timolol maleate
RxNorm normalized name: Timolol Maleate
DrugBank: Timolol (DB00373)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Timolol maleate and bendrofluazide (10 mg timolol and 2-5 mg bendrofluazide, increased as needed)
Trial: 29497287
Drug: NEM 500
RxNorm normalized name: imipenem 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NEM 500 mg
Trial: 24884770
Drug: Patch repair
RxNorm normalized name: hyaluronic acid Ophthalmic Gel [Optimend Corneal Repair]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patch repair
Trial: 18494967
Drug: Ozone followed
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozone followed by P (8% carbamide peroxide solution)
Trial: 18494967
Drug: Ozone concurrently
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozone concurrently with P (8% carbamide peroxide solution)
Trial: 18494967
Drug: P alone
RxNorm normalized name: P & S
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P alone (8% carbamide peroxide solution)
Trial: 16435615
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg of 0.75% ropivacaine + 25 microg of fentanyl
Trial: 16435615
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of 1% ropivacaine + 25 microg of fentanyl
Trial: 10099655
Drug: Adjuvant low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Adjuvant low-dose radiation therapy (LDRT) after chemotherapy with MOPP/ABVD
Trial: 10099655
Drug: Adjuvant low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Adjuvant low-dose radiation therapy (LDRT) after chemotherapy with ABVD
Trial: 10099655
Drug: Adjuvant low-dose
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Adjuvant low-dose radiation therapy (LDRT) after chemotherapy with MOPP/ABVD or ABVD
Trial: 2015545
Drug: 5-fluorouracil (5FU)
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5FU) plus doxorubicin as adjuvant chemotherapy
Trial: 6779618
Drug: Nifedipine, 10
RxNorm normalized name: Nifedipine, 10 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine, 10 mg buccally
Trial: 18839053
Drug: Metformin (1,700
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin (1,700 mg/day)
Trial: 29519921
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg prednisone for 7 days
Trial: 26346638
Drug: Lisdexamfetamine dimesylate
RxNorm normalized name: Lisdexamfetamine Dimesylate
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine dimesylate (LDX) 50 or 70 mg/day
Trial: 26346638
Drug: Lisdexamfetamine dimesylate
RxNorm normalized name: Lisdexamfetamine Dimesylate
DrugBank: Lisdexamfetamine (DB01255)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Lisdexamfetamine dimesylate (LDX) 50 and 70 mg/day
Trial: 17627903
Drug: Intrastricture steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrastricture steroid injection (triamcinolone, 40 mg total dose)
Trial: 12389594
Drug: Transdermal estrogens
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogens (50 microg 17 beta‐Estradiol/24 hr)
Trial: 12389594
Drug: Transdermal estrogens
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogens with progestagens (10 mg daily for last 2 weeks)
Trial: 7936382
Drug: Transdermal estrogens
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogens
Trial: 9649908
Drug: Insulin/C-peptide ratio
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin/C-peptide ratio
Trial: 9649908
Drug: Insulin/C-peptide ratio
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin/C-peptide ratio (excluding muscle morphological variables)
Trial: 8077174
Drug: Lithium treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium treatment (sustained-release form, once a day at night, optimum dosage with plasma level of 0.5-0.79 mmol/L 12 hours after the nightly dose)
Trial: 8077174
Drug: Lithium treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lithium treatment (lower dosage after 1982)
Trial: 2511685
Drug: Buccal NTG
RxNorm normalized name: nitroglycerin Buccal Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buccal NTG (1-3 mg t.i.d., five hourly with an eight-h washout period)
Trial: 17928803
Drug: 8% (w/w)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8% (w/w) solution of galactose (Gal)
Trial: 17928803
Drug: 8% solution
RxNorm normalized name: Topicale 18% Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8% solution of 50% galactose/50% glucose (Gluc/Gal)
Trial: 17928803
Drug: 8% solution
RxNorm normalized name: Topicale 18% Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8% solution of 80% glucose/20% fructose (Gluc/Fru)
Trial: 8512659
Drug: Ro 42-5892
RxNorm normalized name: RO-5045337
DrugBank: RO-5045337 (DB14793)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ro 42-5892 (600 mg)
Trial: 3805544
Drug: Histamine (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine (0.1 mg per nostril)
Trial: 3805544
Drug: Histamine (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine (0.5 mg per nostril)
Trial: 3805544
Drug: Histamine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine (5 mg per nostril)
Trial: 3805544
Drug: Histamine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine (10 mg per nostril)
Trial: 31053954
Drug: Tolvaptan (weight-adjusted
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tolvaptan (weight-adjusted doses, titrated to maintenance dose)
Trial: 21261107
Drug: Perindopril (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril (5 mg once daily, n = 20)
Trial: 21261107
Drug: Rilmenidine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rilmenidine (1 mg once daily, n = 18)
Trial: 21261107
Drug: Telmisartan (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan (40 mg once daily, n = 16)
Trial: 17919555
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate nasal spray 110 microg QD for 2 weeks
Trial: 17919555
Drug: Placebo nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo nasal spray QD for 2 weeks
Trial: 16246948
Drug: cilostazol 100
RxNorm normalized name: cilostazol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: cilostazol 100 mg BID for 6 months
Trial: 11243072
Drug: Purified Verocell
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified Verocell Rabies Vaccine (PVRV)
Trial: 8888092
Drug: Gentamicin-clindamycin (G-C)
RxNorm normalized name: (3'-5')d(c-a-c-g-c-a-c-g-c-g-c-a-t-c-c-c-c-g-c-c-c-g-t-g)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin-clindamycin (G-C)
Trial: 1891675
Drug: Topical vitamin
RxNorm normalized name: vitamin A Topical Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical vitamin A acid at 0.025% for 6 months followed by 0.05%
Trial: 6130243
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (UCT)
Trial: 3720528
Drug: Diazepam (DZ)
DrugBank: Diazepam (DB00829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diazepam (DZ) 80 mg every third day (3 subjects) or every sixth day (3 subjects) for a total of 3-6 dosing occasions
Trial: 3720528
Drug: Triazolam (TZ)
RxNorm normalized name: Triazolam
DrugBank: Triazolam (DB00897)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triazolam (TZ) 2.0 or 3.0 mg every second day (4 subjects) or every third day (2 subjects) for a total of 3-5 dosing occasions
Trial: 30382270
Drug: Strawberry supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strawberry supplementation (50 g day-1 for 12 weeks)
Trial: 30382270
Drug: Placebo (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (50 g day-1, matched for calories and fiber)
Trial: 25684620
Drug: 5 mL
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mL Evicel® (fibrin haemostatic sealant)
Trial: 25684620
Drug: Cost of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cost of treatment with Evicel®
Trial: 20578381
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (therapeutic principle of dredging meridians and collaterals, tonifying qi and eliminating blood stasis, supplementing liver and kidney, nourishing blood and tendon; points included Hegu (LI 4), Taichong (LR 3), Zusanli (ST 36), Qihai (CV 6), Quchi (LI 11))
Trial: 20578381
Drug: Cobamamide (intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cobamamide (intramuscular injection)
Trial: 2510510
Drug: Triple-drug immunosuppressant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple-drug immunosuppressant therapy (cyclosporine, azathioprine, prednisone)
Trial: 2510510
Drug: OKT3 prophylaxis
RxNorm normalized name: Bacillus anthracis strain V770-NP1-R antigens
DrugBank: Anthrax vaccine (DB11003)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OKT3 prophylaxis with 2 g intravenous methylprednisolone
Trial: 776312
Drug: Active medication
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active medication (control group)
Trial: 27594602
Drug: Psychoanalytic Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychoanalytic Therapy (PT)
Trial: 22390832
Drug: One-hour in
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-hour in vivo exposure treatment
Trial: 14520165
Drug: Modafinil 400
RxNorm normalized name: Modafinil
DrugBank: Modafinil (DB00745)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Modafinil 400 mg once daily
Trial: 14520165
Drug: Modafinil 400
RxNorm normalized name: Modafinil
DrugBank: Modafinil (DB00745)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Modafinil 400 mg split dose
Trial: 14520165
Drug: Modafinil 200
RxNorm normalized name: modafinil 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil 200 mg once daily
Trial: 14520165
Drug: Modafinil (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (all doses)
Trial: 30975019
Drug: Cream denture
RxNorm normalized name: ALCOHOL,DENATURED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream denture adhesive
Trial: 27591988
Drug: Topical therapy
RxNorm normalized name: Diclosaicin 1.5%-0.025% Topical Therapy Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical therapy
Trial: 27591988
Drug: Combined topical
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined topical and NB-UVB therapy
Trial: 29915975
Drug: NB-UVB therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NB-UVB therapy
Trial: 25386609
Drug: Cynatine HNS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cynatine HNS (500 mg keratin plus vitamins and minerals)
Trial: 22788983
Drug: Life-review therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Life-review therapy with computer supplements (6 weeks)
Trial: 17607121
Drug: Paclitaxel (110
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel (110 mg/m2 on day 1), topotecan (1.5 mg/m2 on days 2-4), etoposide (160 mg/m2 on days 5-7 every 21 days) followed by chest irradiation to 70 Gy and carboplatin (AUC 5 on day 1) and etoposide (100 mg/m2 on days 1-3 every 21 days) without filgrastim for three cycles.
Trial: 12270981
Drug: Fluvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvastatin (40 mg twice daily, n=11)
Trial: 12270981
Drug: L-arginine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (100 mg/kg/30 min)
Trial: 12270981
Drug: L-arginine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (500 mg/kg/30 min)
Trial: 10097934
Drug: nisoldipine (20-40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nisoldipine (20-40 mg/day)
Trial: 10097934
Drug: lisinopril (10-20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lisinopril (10-20 mg/day)
Trial: 8947977
Drug: Caffeine with
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine with multiple GFJ doses
Trial: 31615021
Drug: Higher preconception
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher preconception vegetable intake (per 10 g/day)
Trial: 31615021
Drug: Higher preconception
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher preconception fruit intake (per 10 g/day)
Trial: 28403943
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D3 (250,000 IU vitamin D3 bolus)
Trial: 17560680
Drug: Terlipressin (1-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terlipressin (1-2 mg/4h) and albumin
Trial: 9474615
Drug: 800 mg
RxNorm normalized name: bran 800 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 mg of oral acyclovir twice daily (1600 mg/day) for 3 to 7 days before sun exposure
Trial: 3565338
Drug: Psyllium (7.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium (7.2 g/day)
Trial: 3565338
Drug: Psyllium plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psyllium plus senna (6.5 + 1.5 g/day)
Trial: 3565338
Drug: Both laxatives
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both laxatives
Trial: 30477852
Drug: 5-week daily
RxNorm normalized name: deutetrabenazine
DrugBank: Deutetrabenazine (DB12161)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 5-week daily use of facial massage roller on the right cheek
Trial: 24700490
Drug: Tafenoquine 1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tafenoquine 1200 mg
Trial: 24700490
Drug: Tafenoquine 600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tafenoquine 600 mg
Trial: 17884359
Drug: Intensive statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive statin therapy (high-dose)
Trial: 17884359
Drug: Moderate statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate statin therapy (standard-dose)
Trial: 8950071
Drug: Captopril (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril (25 mg, given orally)
Trial: 1742248
Drug: Indomethacin 50
RxNorm normalized name: indomethacin 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin 50 mg (Indocid)
Trial: 1742248
Drug: Tiaprofenic acid
RxNorm normalized name: tiaprofenic acid
DrugBank: Tiaprofenic acid (DB01600)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiaprofenic acid 100 mg (Surgam)
Trial: 1742248
Drug: Sodium acetylsalicylate
RxNorm normalized name: acetylsalicylate sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium acetylsalicylate 1 g (Catalgine)
Trial: 7081727
Drug: Intravenous morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous morphine sulfate 10 mg
Trial: 7081727
Drug: Lumbar epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lumbar epidural morphine 10 mg
Trial: 28316174
Drug: ivabradine (starting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ivabradine (starting dose 5 mg bid, uptitrated to 7.5 mg bid)
Trial: 24379072
Drug: Group C
RxNorm normalized name: STREPTOCOCCUS ANTIGEN (GROUP C)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C (Inhalation anesthesia with desflurane)
Trial: 20598710
Drug: rEEG-guided pharmacotherapy
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rEEG-guided pharmacotherapy
Trial: 17511752
Drug: Daily estimation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily estimation assessment procedures
Trial: 14747225
Drug: Caiapo (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caiapo (4 g once daily for 12 weeks)
Trial: 9596235
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (MgSO4) loading infusion of 16 mmol followed by 65 mmol over 24 hours
Trial: 9596235
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (MgSO4) loading infusion of 12 mmol followed by 65 mmol over 24 hours
Trial: 9596235
Drug: Intravenous magnesium
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous magnesium sulfate (MgSO4) loading infusion of 8 mmol followed by 65 mmol over 24 hours
Trial: 2649156
Drug: State-Adjusted Treatment
RxNorm normalized name: CLOZAPINE (GOLDEN STATE)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: State-Adjusted Treatment (SAT)
Trial: 31013550
Drug: Δ9-tetrahydrocannabinol (THC)
RxNorm normalized name: Δ9-tetrahydrocannabinol
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Δ9-tetrahydrocannabinol (THC) (8 mg)
Trial: 31013550
Drug: THC +
RxNorm normalized name: Tetrahydrocannabinol
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: THC + cannabidiol (THC + CBD) (8 + 16 mg)
Trial: 31013550
Drug: CBD (16
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CBD (16 mg)
Trial: 21294997
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg loxapine
Trial: 989370
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg loxapine
Trial: 18246742
Drug: Ceftriaxone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone treatment
Trial: 11565669
Drug: 20-g albumin
RxNorm normalized name: ALBUMIN HUMAN 0.20 g in 1 mL INTRAVENOUS SOLUTION [FLEXBUMIN]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20-g albumin
Trial: 11565669
Drug: 2-g albumin
RxNorm normalized name: albumin human, USP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-g albumin
Trial: 7922833
Drug: Atropine sulphate
RxNorm normalized name: Atropine sulphate
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Atropine sulphate 0.04 mg/kg followed by propranolol 0.2 mg/kg
Trial: 3074299
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg twice daily (Group A)
Trial: 3074299
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg once daily (Group B)
Trial: 21722501
Drug: Hylan G-F20
RxNorm normalized name: HYLAN G-F20 16MG/2ML INJ,SYRINGE,2ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hylan G-F20 (Synvisc)
Trial: 19451093
Drug: Celecoxib 400
RxNorm normalized name: celecoxib 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib 400 mg b.i.d. for 4 weeks
Trial: 16939509
Drug: Combined once
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined once weekly high-velocity varied-resistance and once weekly gymnasium-based functional training (CB)
Trial: 16335645
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg PGE2 vaginal tablets (n = 75)
Trial: 16335645
Drug: 50 mL
RxNorm normalized name: TPN Bag 250 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mL intracervical Foley catheter (n = 72)
Trial: 11046104
Drug: xemilofiban (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: xemilofiban (10 or 20 mg three times daily)
Trial: 9505816
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin at a concentration of 5 IU/ml added to infusion fluid (n = 55)
Trial: 9505816
Drug: No heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No heparin (control group, n = 56)
Trial: 1447436
Drug: Standard electronic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard electronic oral (PO) thermometry